Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Relationship of pleural fluid pH and glucose: a multi-centre study of 2,971 cases.

Fitzgerald DB, Leong SL, Budgeon CA, Murray K, Rosenstengal A, Smith NA, Bielsa S, Clive AO, Maskell NA, Porcel JM, Lee YCG.

J Thorac Dis. 2019 Jan;11(1):123-130. doi: 10.21037/jtd.2018.12.101.

2.

Is there a role for prophylactic radiotherapy to intervention tract sites in patients with malignant pleural mesothelioma?

Halford P, Clive AO.

Transl Lung Cancer Res. 2018 Oct;7(5):584-592. doi: 10.21037/tlcr.2018.07.06. Review.

3.

Providing safe and effective pleural medicine services in the UK: an aspirational statement from UK pleural physicians.

Evison M, Blyth KG, Bhatnagar R, Corcoran J, Saba T, Duncan T, Hallifax R, Ahmed L, West A, Pepperell JCT, Roberts M, Sivasothy P, Psallidas I, Clive AO, Latham J, Stanton AE, Maskell N, Rahman N.

BMJ Open Respir Res. 2018 Aug 3;5(1):e000307. doi: 10.1136/bmjresp-2018-000307. eCollection 2018.

4.

Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial.

Stewart SA, Clive AO, Maskell NA, Penz E.

PLoS One. 2018 Feb 5;13(2):e0190257. doi: 10.1371/journal.pone.0190257. eCollection 2018.

5.

A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural Effusions.

Dixon G, Bhatnagar R, Zahan-Evans N, Clive AO, Virgo PF, Brett MT, Otton SH, Medford ARL, Maskell NA.

Respiration. 2018;95(2):98-105. doi: 10.1159/000481290. Epub 2017 Nov 10.

6.

Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.

Mishra EK, Clive AO, Wills GH, Davies HE, Stanton AE, Al-Aloul M, Hart-Thomas A, Pepperell J, Evison M, Saba T, Harrison RN, Guhan A, Callister ME, Sathyamurthy R, Rehal S, Corcoran JP, Hallifax R, Psallidas I, Russell N, Shaw R, Dobson M, Wrightson JM, West A, Lee YCG, Nunn AJ, Miller RF, Maskell NA, Rahman NM.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):502-508. doi: 10.1164/rccm.201704-0809OC. Erratum in: Am J Respir Crit Care Med. 2018 Apr 15;197(8):1092-1093.

PMID:
28926296
7.

Prophylactic radiotherapy for procedure tract metastases in mesothelioma: a review.

Arnold DT, Clive AO.

Curr Opin Pulm Med. 2017 Jul;23(4):357-364. doi: 10.1097/MCP.0000000000000385. Review.

PMID:
28426469
8.

Prophylactic radiotherapy to prevent procedure-tract metastases - Author's reply.

Clive AO, Taylor H, Maskell NA.

Lancet Oncol. 2016 Oct;17(10):e419. doi: 10.1016/S1470-2045(16)30454-5. No abstract available.

PMID:
27733265
9.

Cochrane corner: interventions for the management of malignant pleural effusions.

Clive AO, Bhatnagar R, Preston NJ, Maskell NA, Jones HE.

Thorax. 2016 Oct;71(10):964-6. doi: 10.1136/thoraxjnl-2016-208989. Epub 2016 Jul 14.

PMID:
27418604
10.

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.

Clive AO, Taylor H, Dobson L, Wilson P, de Winton E, Panakis N, Pepperell J, Howell T, Stewart SA, Penz E, Jordan N, Morley AJ, Zahan-Evans N, Smith S, Batchelor TJP, Marchbank A, Bishop L, Ionescu AA, Bayne M, Cooper S, Kerry A, Jenkins P, Toy E, Vigneswaran V, Gildersleve J, Ahmed M, McDonald F, Button M, Lewanski C, Comins C, Dakshinamoorthy M, Lee YCG, Rahman NM, Maskell NA.

Lancet Oncol. 2016 Aug;17(8):1094-1104. doi: 10.1016/S1470-2045(16)30095-X. Epub 2016 Jun 23.

11.

Interventions for the management of malignant pleural effusions: a network meta-analysis.

Clive AO, Jones HE, Bhatnagar R, Preston NJ, Maskell N.

Cochrane Database Syst Rev. 2016 May 8;(5):CD010529. doi: 10.1002/14651858.CD010529.pub2. Review.

12.

Individualised management of malignant pleural effusion.

Clive AO, Bhatnagar R, Psallidas I, Maskell NA.

Lancet Respir Med. 2015 Jul;3(7):505-6. doi: 10.1016/S2213-2600(15)00183-6. No abstract available.

PMID:
26170072
13.

Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection.

Hooper CE, Edey AJ, Wallis A, Clive AO, Morley A, White P, Medford AR, Harvey JE, Darby M, Zahan-Evans N, Maskell NA.

Eur Respir J. 2015 Aug;46(2):456-63. doi: 10.1183/09031936.00147214. Epub 2015 May 28.

14.

A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study.

Clive AO, Hooper CE, Edey AJ, Morley AJ, Zahan-Evans N, Hall D, Lyburn I, White P, Braybrooke JP, Sequeiros I, Lyen SM, Milton T, Kahan BC, Maskell NA.

PLoS One. 2015 Mar 17;10(3):e0118569. doi: 10.1371/journal.pone.0118569. eCollection 2015.

15.

Pleural fluid adenosine deaminase (pfADA) in the diagnosis of tuberculous effusions in a low incidence population.

Arnold DT, Bhatnagar R, Fairbanks LD, Zahan-Evans N, Clive AO, Morley AJ, Medford AR, Maskell NA.

PLoS One. 2015 Feb 3;10(2):e0113047. doi: 10.1371/journal.pone.0113047. eCollection 2015.

16.

Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases.

Clive AO, Wilson P, Taylor H, Morley AJ, de Winton E, Panakis N, Rahman N, Pepperell J, Howell T, Batchelor TJ, Jordan N, Lee YC, Dobson L, Maskell NA.

BMJ Open. 2015 Jan 9;5(1):e006673. doi: 10.1136/bmjopen-2014-006673.

17.

Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.

Bibby AC, Clive AO, Slade GC, Morley AJ, Fallon J, Psallidas I, Pepperell JCT, Slade MG, Stanton AE, Rahman NM, Maskell NA.

Chest. 2015 Jul;148(1):235-241. doi: 10.1378/chest.14-2199.

PMID:
25429399
18.

Authors' response to Murray et al.

Clive AO, Kahan BC, Maskell NA.

Thorax. 2014 Dec;69(12):1144-5. doi: 10.1136/thoraxjnl-2014-206247. Epub 2014 Sep 24. No abstract available.

PMID:
25253357
19.

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.

Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, Bintcliffe OJ, Boshuizen RC, Fysh ET, Tobin CL, Medford AR, Harvey JE, van den Heuvel MM, Lee YC, Maskell NA.

Thorax. 2014 Dec;69(12):1098-104. doi: 10.1136/thoraxjnl-2014-205285. Epub 2014 Aug 6.

20.

Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice.

Bhatnagar R, Reid ED, Corcoran JP, Bagenal JD, Pope S, Clive AO, Zahan-Evans N, Froeschle PO, West D, Rahman NM, Chatterji S, Sivasothy PR, Maskell NA.

Thorax. 2014 Oct;69(10):959-61. doi: 10.1136/thoraxjnl-2013-204563. Epub 2013 Dec 16.

PMID:
24343783
21.

Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study.

Fysh ETH, Tremblay A, Feller-Kopman D, Mishra EK, Slade M, Garske L, Clive AO, Lamb C, Boshuizen R, Ng BJ, Rosenstengel AW, Yarmus L, Rahman NM, Maskell NA, Lee YCG.

Chest. 2013 Nov;144(5):1597-1602. doi: 10.1378/chest.12-3103.

PMID:
23828305

Supplemental Content

Loading ...
Support Center